Key result
Higher BMI z-score in youth with type 1 diabetes is linked to worse cardiometabolic markers.
Why the study?
The additional cardiovascular risk associated with overweight in youth with type 1 diabetes was not well characterized.
Observational (n=7,061)
Yes
Mean Difference: 0.16 (95% CI 0.13–0.18)
p-value: p=< 0.001
May warrant closer cardiometabolic monitoring with rising BMI in youth with type 1 diabetes; hypothesis-generating for targeted interventions.
CONTEXT: Cardiovascular disease occurs prematurely in type 1 diabetes. The additional risk of overweight is not well characterized. OBJECTIVE: The primary aim was to measure the impact of body mass index (BMI) in youth with type 1 diabetes on cardiovascular risk factors. The secondary aim was to identify other determinants of cardiovascular risk. DESIGN: Observational longitudinal study of 7061 youth with type 1 diabetes followed for median 7.3 (interquartile range [IQR] 4-11) years over 41 (IQR 29-56) visits until March 2019. SETTING: 15 tertiary care diabetes centers in the Australasian Diabetes Data Network.Participants were aged 2 to 25 years at baseline, with at least 2 measurements of BMI and blood pressure. MAIN OUTCOME MEASURE: Standardized systolic and diastolic blood pressure scores and non-high-density lipoprotein (HDL) cholesterol were co-primary outcomes. Urinary albumin/creatinine ratio was the secondary outcome. RESULTS: BMI z-score related independently to standardized blood pressure z- scores and non-HDL cholesterol. An increase in 1 BMI z-score related to an average increase in systolic/diastolic blood pressure of 3.8/1.4 mmHg and an increase in non-HDL cholesterol (coefficient + 0.16 mmol/L, 95% confidence interval [CI], 0.13-0.18; P < 0.001) and in low-density lipoprotein (LDL) cholesterol. Females had higher blood pressure z-scores, higher non-HDL and LDL cholesterol, and higher urinary albumin/creatinine than males. Indigenous youth had markedly higher urinary albumin/creatinine (coefficient + 2.15 mg/mmol, 95% CI, 1.27-3.03; P < 0.001) and higher non-HDL cholesterol than non-Indigenous youth. Continuous subcutaneous insulin infusion was associated independently with lower non-HDL cholesterol and lower urinary albumin/creatinine. CONCLUSIONS: BMI had a modest independent effect on cardiovascular risk. Females and Indigenous Australians in particular had a more adverse risk profile.
No takes yet. Share an insight, caveat, or question.
Couper et al. (2020) conducted an observational in Type 1 diabetes (n=7,061). Body mass index (BMI) was evaluated on Standardized systolic and diastolic blood pressure scores and non-high-density lipoprotein (HDL) cholesterol (coefficient + 0.16 mmol/L, 95% CI 0.13-0.18, p=< 0.001). An increase of 1 BMI z-score in youth with type 1 diabetes was associated with higher blood pressure (3.8/1.4 mmHg) and non-HDL cholesterol (+0.16 mmol/L; 95% CI 0.13-0.18; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: